We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Macerich
MAC
$6.35B
| $9.15M | 0.03% |
1,152,481
+206,359
| +22% | +$2M |
|
|
SHYF
552
DELISTED
The Shyft Group
SHYF
| $9.15M | 0.03% |
447,667
+110,192
| +33% | +$2.57M |
|
553
Chord Energy
CHRD
$8.59B
| $9.13M | 0.03% |
66,773
+15,277
| +30% | +$1.96M |
|
|
VRTV
554
DELISTED
VERITIV CORPORATION
VRTV
| $8.98M | 0.03% |
91,872
+21,597
| +31% | +$2.57M |
|
555
Molson Coors Class B
TAP
$7.32B
| $8.82M | 0.03% |
183,780
-87,783
| -32% | -$4.76M |
|
556
Stanley Black & Decker
SWK
$13.4B
| $8.8M | 0.03% |
+116,973
| New | +$11.3M |
|
557
Curtiss-Wright
CW
$20.8B
| $8.79M | 0.03% |
63,145
+13,147
| +26% | +$1.87M |
|
558
QCR Holdings
QCRH
$1.68B
| $8.76M | 0.03% |
171,878
+297
| +0.2% | +$16.6K |
|
559
The Kraft Heinz Company
KHC
$29.3B
| $8.69M | 0.03% |
260,534
-106
| -0% | -$3.94K |
|
560
Allegion
ALLE
$13.1B
| $8.62M | 0.03% |
96,079
-27,503
| -22% | -$2.72M |
|
|
CMBM
561
DELISTED
Cambium Networks
CMBM
| $8.61M | 0.03% |
509,090
-17,348
| -3% | -$311K |
|
562
Bank of Montreal
BMO
$121B
| $8.51M | 0.02% |
97,073
-917
| -0.9% | -$88.7K |
|
563
Emergent Biosolutions
EBS
$326M
| $8.45M | 0.02% |
402,698
+380,668
| +1,728% | +$10.6M |
|
564
Sociedad Química y Minera de Chile
SQM
$19.8B
| $8.45M | 0.02% |
93,111
+11,052
| +13% | +$1.07M |
|
565
Amalgamated Financial
AMAL
$1.41B
| $8.44M | 0.02% |
374,430
+248,661
| +198% | +$5.58M |
|
566
Organogenesis Holdings
ORGO
$188M
| $8.43M | 0.02% |
2,600,944
+8,932
| +0.3% | +$40.4K |
|
567
Royal Bank of Canada
RY
$283B
| $8.42M | 0.02% |
93,508
-440
| -0.5% | -$42.2K |
|
568
CME Group
CME
$98.9B
| $8.38M | 0.02% |
47,334
-15,819
| -25% | -$3.13M |
|
|
VGR
569
DELISTED
Vector Group Ltd.
VGR
| $8.37M | 0.02% |
949,682
-4,440
| -0.5% | -$45K |
|
|
NVO
570
Novo Nordisk
NVO
$188B
| $8.35M | 0.02% |
167,612
+1,060
| +0.6% | +$56.8K |
|
|
HSKA
571
DELISTED
Heska Corp
HSKA
| $8.32M | 0.02% |
114,124
+112,169
| +5,738% | +$9.91M |
|
572
Jack Henry & Associates
JKHY
$10.8B
| $8.27M | 0.02% |
45,371
-1,950
| -4% | -$383K |
|
573
Guidewire Software
GWRE
$12.2B
| $8.25M | 0.02% |
+134,035
| New | +$9.69M |
|
574
Trip.com Group
TCOM
$24.7B
| $8.25M | 0.02% |
302,090
+1,908
| +0.6% | +$50K |
|
|
MNTV
575
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $8.18M | 0.02% |
1,407,572
+1,387,490
| +6,909% | +$10.8M |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.